Hi barra, hopefully that non diluted funding will come via a...

Hi barra, hopefully that non diluted funding will come via a TAVR deal rather than a loan, that aside when I saw your figure of fifty cents I thought whoa .... that much!

Here is some very simplistic maths to test that figure, I will use BIT and RAP as comparisons. Not going to touch on revenue, cash burn or success or not of their individual science.

AHZ; Market cap of 32 mill with approx 533 mill shares, add to this, another 150 mill once 8 cent options exercised, say another (?) 50 mill from 25 cent options and new options to BOD/WP this AGM, this makes approx 730 mill shares possibly on issue.

BIT; Market cap of 47 mill with approx 595 mill shares, options (?) Not researched.

RAP; Market cap of 118 mill with approx 813 mill shares, options (?) Not researched.

Prices; AHZ- 6 cents, RAP-$1.45 and BIT 79 cents, last two prices are done with a ten to one consolidation in mind.

Have a think about this!, AHZ to have sp of fifty cent plus really seems achievable, (conditional on the appropriate funding, imo), all three in a similar range in number of shares on issue.

Also bear in mind what all three have or not have!.


If WP can bring home a significant deal with the TAVR then at long last something very good may come out of the mess Admedus has been in, despite 40 % stake in the company song at bargain rates in the interim.

Happy for the above to be pulled apart, may have overlooked something important.